|
ACON
|
Aclarion, Inc.
|
US
|
NASDAQ
|
|
ANNX
|
Annexon, Inc.
|
US
|
NASDAQ
|
|
AVEO
|
AVEO Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
AVTX
|
Avalo Therapeutics, Inc.
|
US
|
NASDAQ
|
|
AYLA
|
Ayala Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
BJDX
|
Bluejay Diagnostics, Inc.
|
US
|
NASDAQ
|
|
BNTX
|
BioNTech SE
|
US
|
NASDAQ
|
|
CGEN
|
Compugen Ltd.
|
US
|
NASDAQ
|
|
CNTG
|
Centogene N.V.
|
US
|
NASDAQ
|
|
HTGM
|
HTG Molecular Diagnostics, Inc.
|
US
|
NASDAQ
|
|
ICLR
|
ICON plc
|
US
|
NASDAQ
|
|
IDYA
|
IDEAYA Biosciences, Inc.
|
US
|
NASDAQ
|
|
LIXT
|
Lixte Biotechnology Holdings, Inc.
|
US
|
NASDAQ
|
|
MYGN
|
Myriad Genetics, Inc.
|
US
|
NASDAQ
|
|
OLK
|
Olink Holding AB
|
US
|
NASDAQ
|
|
OPK
|
OPKO Health Inc.
|
US
|
NASDAQ
|
|
POAI
|
Predictive Oncology Inc.
|
US
|
NASDAQ
|
|
PRTC
|
PureTech Health plc
|
US
|
NASDAQ
|
|
QTRX
|
Quanterix Corporation
|
US
|
NASDAQ
|
|
SAVA
|
Cassava Sciences, Inc.
|
US
|
NASDAQ
|